HLA-F Complex Without Peptide Binds to MHC Class I Protein in the Open Conformer Form
Overview
Affiliations
HLA-F has low levels of polymorphism in humans and is highly conserved among primates, suggesting a conserved function in the immune response. In this study, we probed the structure of HLA-F on the surface of B lymphoblastoid cell lines and activated lymphocytes by direct measurement of peptide binding to native HLA-F. Our findings suggested that HLA-F is expressed independently of bound peptide, at least in regard to peptide complexity profiles similar to those of either HLA-E or classical MHC class I (MHC-I). As a further probe of native HLA-F structure, we used a number of complementary approaches to explore the interactions of HLA-F with other molecules, at the cell surface, intracellularly, and in direct physical biochemical measurements. This analysis demonstrated that HLA-F surface expression was coincident with MHC-I H chain (HC) expression and was downregulated upon perturbation of MHC-I HC structure. It was further possible to directly demonstrate that MHC-I would interact with HLA-F only when in the form of an open conformer free of peptide and not as a trimeric complex. This interaction was directly observed by coimmunoprecipitation and by surface plasmon resonance and indirectly on the surface of cells through coincident tetramer and MHC-I HC colocalization. These data suggest that HLA-F is expressed independently of peptide and that a physical interaction specific to MHC-I HC plays a role in the function of MHC-I HC expression in activated lymphocytes.
Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Filippone E Curr Issues Mol Biol. 2024; 46(7):6961-6985.
PMID: 39057057 PMC: 11276036. DOI: 10.3390/cimb46070416.
Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Filippone E Antibodies (Basel). 2024; 13(1).
PMID: 38390869 PMC: 10885067. DOI: 10.3390/antib13010008.
and Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease.
Bernit E, Jean E, Marlot B, Laget L, Izard C, Dettori I Int J Mol Sci. 2023; 24(17).
PMID: 37686397 PMC: 10487752. DOI: 10.3390/ijms241713591.
Ravindranath M, Ravindranath N, Selvan S, Hilali F, Amato-Menker C, Filippone E Biomolecules. 2023; 13(8).
PMID: 37627243 PMC: 10452486. DOI: 10.3390/biom13081178.
Non-Classical HLA Class 1b and Hepatocellular Carcinoma.
De Re V, Tornesello M, Racanelli V, Prete M, Steffan A Biomedicines. 2023; 11(6).
PMID: 37371767 PMC: 10296335. DOI: 10.3390/biomedicines11061672.